UK medicines regulator issues its first authorisation under Project Orbis
A post-surgery treatment for lung cancer will be the first to receive an authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) under Project Orbis – only four months after the agency joined the scheme in January 2021. Osime… read more